Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Negative Opinions Include Fear of Clinical Trials: CMIC
March 3, 2008
- TOPICS／Pfizer Foundation Supports 2 Japanese NGOs to Fight Tobacco and Breast Cancer
March 3, 2008
- Korosho to Meet Concerned Parties to Improve Drug Distribution Practices
February 25, 2008
- OPINION／The Hottest Jobs in 2008 Revealed
February 25, 2008
- SSP to Promote Core Brand Strategy Based on 8 Products
February 25, 2008
- MEDICAL DEVICE NEWS IN BRIEF
February 25, 2008
- AZ Trains District Managers to Enhance Its Sales Forces
February 25, 2008
- Mediceo Paltac to Deal with Generics in Earnest
February 25, 2008
- Novartis to Launch Galvus in Europe
February 25, 2008
- Hansha Must Deal with Generics from All Companies: Mr Eguchi of Seibu Sawai
February 25, 2008
- FY2008 Revision of Medical Fees Recommended by Chuikyo
February 25, 2008
- Premium of 4 Points to Be Paid to Heavy Generic Dispensers
February 25, 2008
- BUSINESS NEWS IN BRIEF
February 25, 2008
- Generics to Be NHI Price Listed in May and November from FY2009
February 25, 2008
- NHI Pricing Procedures to See Changes
February 25, 2008
- TOPICS／Poster Prepared by Korosho to Promote Use of Generics
February 25, 2008
- JPA Satisfied with Proposed Dispensing Fees: JPA Vice President
February 25, 2008
- Piecework System Should Be Applied to Drugs Used at Nursing Care Facilities
February 25, 2008
- MTX Recommended for Approval for JIA
February 25, 2008
- New System to Cover Certain Unapproved Medical Services by Insurance from April
February 25, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…